Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus.

Rachel Lieberman, Donghai Xiong, Michael James, Younghun Han, Christopher I Amos, Liang Wang, Ming You
Author Information
  1. Rachel Lieberman: Department of Pharmacology & Toxicology and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
  2. Donghai Xiong: Department of Pharmacology & Toxicology and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
  3. Michael James: Department of Pharmacology & Toxicology and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
  4. Younghun Han: Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire.
  5. Christopher I Amos: Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire.
  6. Liang Wang: Department of Pathology and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
  7. Ming You: Department of Pharmacology & Toxicology and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin.

Abstract

Recent genome-wide association studies have identified variations in the recombination repair gene, RAD52, that are associated with increased lung cancer risk, and particularly with the development of lung squamous cell carcinomas (LUSC). As LUSC development is strongly associated with smoking, DNA repair is increased in the lung tissues of smokers, presumably because of ongoing DNA damage from exposure to tobacco smoke. A key player in the DNA damage response, RAD52 plays a role in DNA strand exchange and annealing during homologous recombination (HR) in mammalian cells. In this study, we discovered two cis-expression quantitative trait loci (eQTL) SNPs in the RAD52 gene that are associated with its expression and are also associated with LUSC risk. In addition, we report that amplification of the genomic region 12p13.33, which contains the RAD52 gene, is significantly associated with the development of LUSC in the TCGA database and that somatic overexpression of RAD52 was confirmed to be significant in LUSC tumors from our own patient cohort. Consistent with these genetic findings, we demonstrate that blockade of Rad52 slows cell growth and induces senescence in mouse bronchial epithelial cells. In contrast, overexpression of Rad52 leads to an increased rate of cell proliferation. We show that depletion of Rad52 in mouse lung tumor cells alters cell cycle distribution and increases DNA damage accumulation associated with increased tumor cell death. Our genetic and functional data implicate RAD52 as a significant determinant of risk in the development of LUSC.

Keywords

References

  1. Exp Lung Res. 2001 Apr-May;27(3):297-318 [PMID: 11293330]
  2. Mol Cell. 2006 Jan 20;21(2):201-14 [PMID: 16427010]
  3. Nucleic Acids Res. 2001 Nov 1;29(21):4352-60 [PMID: 11691922]
  4. Nat Cell Biol. 2002 Dec;4(12):993-7 [PMID: 12447390]
  5. Nat Cell Biol. 2003 Jul;5(7):675-9 [PMID: 12792649]
  6. Cell Cycle. 2003 Sep-Oct;2(5):479-83 [PMID: 12963848]
  7. Oncogene. 2004 Jun 10;23(27):4655-61 [PMID: 15122331]
  8. Mol Cell Biol. 2004 Oct;24(20):9006-18 [PMID: 15456874]
  9. Mol Cell Biol. 1998 Nov;18(11):6423-9 [PMID: 9774658]
  10. Oncogene. 2008 Nov 6;27(52):6623-34 [PMID: 18679422]
  11. Mol Cell Biol. 2009 May;29(10):2828-40 [PMID: 19273588]
  12. Lancet Oncol. 2010 Apr;11(4):321-30 [PMID: 20304703]
  13. Annu Rev Genet. 2010;44:113-39 [PMID: 20690856]
  14. Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):686-91 [PMID: 21148102]
  15. Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):441-2 [PMID: 21189297]
  16. Cancer Discov. 2012 Feb;2(2):131-9 [PMID: 22585858]
  17. Cell. 2012 Sep 14;150(6):1121-34 [PMID: 22980976]
  18. Clin Cancer Res. 2012 Dec 1;18(23):6400-6 [PMID: 23071261]
  19. Oncogene. 2013 Jul 25;32(30):3552-8 [PMID: 22964643]
  20. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29 [PMID: 24399786]
  21. Nat Genet. 2014 Jul;46(7):736-41 [PMID: 24880342]
  22. Nat Rev Genet. 2006 Feb;7(2):85-97 [PMID: 16418744]
  23. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8276-82 [PMID: 11459964]

Grants

  1. P30 CA023108/NCI NIH HHS
  2. U19 CA148127/NCI NIH HHS
  3. U19CA148127/NCI NIH HHS

MeSH Term

Animals
Carcinoma, Squamous Cell
Cell Line, Tumor
Cell Proliferation
Chromosomes, Human, Pair 12
DNA Damage
Gene Amplification
Genetic Predisposition to Disease
Humans
Lung Neoplasms
Mice
Neoplasm Transplantation
Polymorphism, Single Nucleotide
Quantitative Trait Loci
Rad52 DNA Repair and Recombination Protein
White People

Chemicals

RAD52 protein, human
Rad52 DNA Repair and Recombination Protein

Word Cloud

Created with Highcharts 10.0.0RAD52lunggeneassociatedcellLUSCDNAincreasedcancerdevelopmentdamageriskcellsRad52recombinationrepaireQTLamplification12p1333overexpressionsignificantgeneticsenescencemousetumorsusceptibilityRecentgenome-wideassociationstudiesidentifiedvariationsparticularlysquamouscarcinomasstronglysmokingtissuessmokerspresumablyongoingexposuretobaccosmokekeyplayerresponseplaysrolestrandexchangeannealinghomologousHRmammalianstudydiscoveredtwocis-expressionquantitativetraitlociSNPsexpressionalsoadditionreportgenomicregioncontainssignificantlyTCGAdatabasesomaticconfirmedtumorspatientcohortConsistentfindingsdemonstrateblockadeslowsgrowthinducesbronchialepithelialcontrastleadsrateproliferationshowdepletionalterscycledistributionincreasesaccumulationdeathfunctionaldataimplicatedeterminantFunctionalcharacterizationlocusnon-smallcarcinoma

Similar Articles

Cited By